Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 43,674 shares at $4.27 ($188K) on 2021-12-15, disclosed to the SEC on 2021-12-15.
Open-market sale of $188k PRTK by Chief Development & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.42 | 4,479 | $20K | 10.5% |
| 2 | $4.37 | 7,635 | $33K | 17.8% |
| 3 | $4.27 | 15,780 | $67K | 35.9% |
| 4 | $4.27 | 15,780 | $67K | 35.9% |
| Total | $4.30 avg | 43,674 | $188K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |